Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

A Reduction in B, T, and Natural Killer Cells Expressing CD38 by TAK-079 Inhibits the Induction and Progression of Collagen-Induced Arthritis in Cynomolgus Monkeys.

Korver W, Carsillo M, Yuan J, Idamakanti N, Wagoner M, Shi P, Xia CQ, Smithson G, McLean L, Zalevsky J, Fedyk ER.

J Pharmacol Exp Ther. 2019 Aug;370(2):182-196. doi: 10.1124/jpet.119.256602. Epub 2019 May 13.

PMID:
31085699
2.

Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension Models.

Yamada K, Levell J, Yoon T, Kohls D, Yowe D, Rigel DF, Imase H, Yuan J, Yasoshima K, DiPetrillo K, Monovich L, Xu L, Zhu M, Kato M, Jain M, Idamakanti N, Taslimi P, Kawanami T, Argikar UA, Kunjathoor V, Xie X, Yagi YI, Iwaki Y, Robinson Z, Park HM.

J Med Chem. 2017 Aug 24;60(16):7099-7107. doi: 10.1021/acs.jmedchem.7b00708. Epub 2017 Aug 3.

PMID:
28771350
3.

Small-molecule WNK inhibition regulates cardiovascular and renal function.

Yamada K, Park HM, Rigel DF, DiPetrillo K, Whalen EJ, Anisowicz A, Beil M, Berstler J, Brocklehurst CE, Burdick DA, Caplan SL, Capparelli MP, Chen G, Chen W, Dale B, Deng L, Fu F, Hamamatsu N, Harasaki K, Herr T, Hoffmann P, Hu QY, Huang WJ, Idamakanti N, Imase H, Iwaki Y, Jain M, Jeyaseelan J, Kato M, Kaushik VK, Kohls D, Kunjathoor V, LaSala D, Lee J, Liu J, Luo Y, Ma F, Mo R, Mowbray S, Mogi M, Ossola F, Pandey P, Patel SJ, Raghavan S, Salem B, Shanado YH, Trakshel GM, Turner G, Wakai H, Wang C, Weldon S, Wielicki JB, Xie X, Xu L, Yagi YI, Yasoshima K, Yin J, Yowe D, Zhang JH, Zheng G, Monovich L.

Nat Chem Biol. 2016 Nov;12(11):896-898. doi: 10.1038/nchembio.2168. Epub 2016 Sep 5.

PMID:
27595330
4.

Discovery and Characterization of Allosteric WNK Kinase Inhibitors.

Yamada K, Zhang JH, Xie X, Reinhardt J, Xie AQ, LaSala D, Kohls D, Yowe D, Burdick D, Yoshisue H, Wakai H, Schmidt I, Gunawan J, Yasoshima K, Yue QK, Kato M, Mogi M, Idamakanti N, Kreder N, Drueckes P, Pandey P, Kawanami T, Huang W, Yagi YI, Deng Z, Park HM.

ACS Chem Biol. 2016 Dec 16;11(12):3338-3346. Epub 2016 Oct 19.

PMID:
27712055
5.

Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma.

Johnson LA, Scholler J, Ohkuri T, Kosaka A, Patel PR, McGettigan SE, Nace AK, Dentchev T, Thekkat P, Loew A, Boesteanu AC, Cogdill AP, Chen T, Fraietta JA, Kloss CC, Posey AD Jr, Engels B, Singh R, Ezell T, Idamakanti N, Ramones MH, Li N, Zhou L, Plesa G, Seykora JT, Okada H, June CH, Brogdon JL, Maus MV.

Sci Transl Med. 2015 Feb 18;7(275):275ra22. doi: 10.1126/scitranslmed.aaa4963.

6.

Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma.

Liu Z, Zhao X, Mao H, Baxter PA, Huang Y, Yu L, Wadhwa L, Su JM, Adesina A, Perlaky L, Hurwitz M, Idamakanti N, Police SR, Hallenbeck PL, Hurwitz RL, Lau CC, Chintagumpala M, Blaney SM, Li XN.

Neuro Oncol. 2013 Sep;15(9):1173-85. doi: 10.1093/neuonc/not065. Epub 2013 May 7.

7.

Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001.

Poirier JT, Reddy PS, Idamakanti N, Li SS, Stump KL, Burroughs KD, Hallenbeck PL, Rudin CM.

J Gen Virol. 2012 Dec;93(Pt 12):2606-13. doi: 10.1099/vir.0.046011-0. Epub 2012 Sep 12.

PMID:
22971818
8.

Structural features of the Seneca Valley virus internal ribosome entry site (IRES) element: a picornavirus with a pestivirus-like IRES.

Willcocks MM, Locker N, Gomwalk Z, Royall E, Bakhshesh M, Belsham GJ, Idamakanti N, Burroughs KD, Reddy PS, Hallenbeck PL, Roberts LO.

J Virol. 2011 May;85(9):4452-61. doi: 10.1128/JVI.01107-10. Epub 2011 Feb 16.

9.

A single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models.

Yu L, Baxter PA, Zhao X, Liu Z, Wadhwa L, Zhang Y, Su JM, Tan X, Yang J, Adesina A, Perlaky L, Hurwitz M, Idamakanti N, Police SR, Hallenbeck PL, Blaney SM, Chintagumpala M, Hurwitz RL, Li XN.

Neuro Oncol. 2011 Jan;13(1):14-27. doi: 10.1093/neuonc/noq148. Epub 2010 Nov 12.

10.

Structure of Seneca Valley Virus-001: an oncolytic picornavirus representing a new genus.

Venkataraman S, Reddy SP, Loo J, Idamakanti N, Hallenbeck PL, Reddy VS.

Structure. 2008 Oct 8;16(10):1555-61. doi: 10.1016/j.str.2008.07.013.

11.

Crystallization and preliminary X-ray diffraction studies of Seneca Valley virus-001, a new member of the Picornaviridae family.

Venkataraman S, Reddy SP, Loo J, Idamakanti N, Hallenbeck PL, Reddy VS.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Apr 1;64(Pt 4):293-6. doi: 10.1107/S1744309108006921. Epub 2008 Mar 21.

12.

Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers.

Reddy PS, Burroughs KD, Hales LM, Ganesh S, Jones BH, Idamakanti N, Hay C, Li SS, Skele KL, Vasko AJ, Yang J, Watkins DN, Rudin CM, Hallenbeck PL.

J Natl Cancer Inst. 2007 Nov 7;99(21):1623-33. Epub 2007 Oct 30.

13.

Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice.

Ganesh S, Gonzalez Edick M, Idamakanti N, Abramova M, Vanroey M, Robinson M, Yun CO, Jooss K.

Cancer Res. 2007 May 1;67(9):4399-407. Erratum in: Cancer Res. 2007 Jun 15;67(12):5998.

14.

Generation of recombinant adenovirus using the Escherichia coli BJ5183 recombination system.

Reddy PS, Ganesh S, Hawkins L, Idamakanti N.

Methods Mol Med. 2007;130:61-8.

PMID:
17401164
15.

Dual promoter-controlled oncolytic adenovirus CG5757 has strong tumor selectivity and significant antitumor efficacy in preclinical models.

Li Y, Idamakanti N, Arroyo T, Thorne S, Reid T, Nichols S, VanRoey M, Colbern G, Nguyen N, Tam O, Working P, Yu DC.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8845-55.

16.

Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates.

Smith TA, Idamakanti N, Marshall-Neff J, Rollence ML, Wright P, Kaloss M, King L, Mech C, Dinges L, Iverson WO, Sherer AD, Markovits JE, Lyons RM, Kaleko M, Stevenson SC.

Hum Gene Ther. 2003 Nov 20;14(17):1595-604.

PMID:
14633402
17.

Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice.

Smith TA, Idamakanti N, Rollence ML, Marshall-Neff J, Kim J, Mulgrew K, Nemerow GR, Kaleko M, Stevenson SC.

Hum Gene Ther. 2003 May 20;14(8):777-87.

PMID:
12804140
18.

In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.

Smith T, Idamakanti N, Kylefjord H, Rollence M, King L, Kaloss M, Kaleko M, Stevenson SC.

Mol Ther. 2002 Jun;5(6):770-9.

19.

Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization.

Kim J, Smith T, Idamakanti N, Mulgrew K, Kaloss M, Kylefjord H, Ryan PC, Kaleko M, Stevenson SC.

J Virol. 2002 Feb;76(4):1892-903.

20.

Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector.

Reddy PS, Sakhuja K, Ganesh S, Yang L, Kayda D, Brann T, Pattison S, Golightly D, Idamakanti N, Pinkstaff A, Kaloss M, Barjot C, Chamberlain JS, Kaleko M, Connelly S.

Mol Ther. 2002 Jan;5(1):63-73.

21.

Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.

Bristol JA, Gallo-Penn A, Andrews J, Idamakanti N, Kaleko M, Connelly S.

Hum Gene Ther. 2001 Sep 1;12(13):1651-61.

PMID:
11535168
22.

Optimization of bovine coronavirus hemagglutinin-estrase glycoprotein expression in E3 deleted bovine adenovirus-3.

Reddy PS, Idamakanti N, Zakhartchouk LN, Babiuk LA, Mehtali M, Tikoo SK.

Virus Res. 2000 Sep;70(1-2):65-73.

PMID:
11074126
23.

The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle.

Reddy PS, Idamakanti N, Pyne C, Zakhartchouk AN, Godson DL, Papp Z, Baca-Estrada ME, Babiuk LA, Mutwiri GK, Tikoo SK.

Vet Immunol Immunopathol. 2000 Oct 31;76(3-4):257-68.

PMID:
11044558
24.

In vivo dose threshold effect of adenovirus-mediated factor VIII gene therapy in hemophiliac mice.

Bristol JA, Shirley P, Idamakanti N, Kaleko M, Connelly S.

Mol Ther. 2000 Sep;2(3):223-32.

25.

Porcine adenovirus-3 as a helper-dependent expression vector.

Reddy PS, Idamakanti N, Babiuk LA, Mehtali M, Tikoo SK.

J Gen Virol. 1999 Nov;80 ( Pt 11):2909-16.

PMID:
10580052
26.

Replication-defective bovine adenovirus type 3 as an expression vector.

Reddy PS, Idamakanti N, Chen Y, Whale T, Babiuk LA, Mehtali M, Tikoo SK.

J Virol. 1999 Nov;73(11):9137-44.

27.
28.

Development of porcine adenovirus-3 as an expression vector.

Reddy PS, Idamakanti N, Hyun BH, Tikoo SK, Babiuk LA.

J Gen Virol. 1999 Mar;80 ( Pt 3):563-70.

PMID:
10091994
29.

Characterization of early region 1 and pIX of bovine adenovirus-3.

Reddy PS, Chen Y, Idamakanti N, Pyne C, Babiuk LA, Tikoo SK.

Virology. 1999 Jan 20;253(2):299-308.

30.

Sequence and transcription map analysis of early region-1 of porcine adenovirus type-3.

Reddy PS, Idamakanti N, Song JY, Lee JB, Hyun BH, Park JH, Cha SH, Tikoo SK, Babiuk LA.

Virus Res. 1998 Nov;58(1-2):97-106.

PMID:
9879766
31.

Nucleotide sequence and transcription map of porcine adenovirus type 3.

Reddy PS, Idamakanti N, Song JY, Lee JB, Hyun BH, Park JH, Cha SH, Bae YT, Tikoo SK, Babiuk LA.

Virology. 1998 Nov 25;251(2):414-26.

32.

Genetic organization and DNA sequence of early region 4 of bovine adenovirus type 3.

Lee JB, Baxi MK, Idamakanti N, Reddy PS, Zakhartchouk AN, Pyne C, Babiuk LA, Tikoo SK.

Virus Genes. 1998;17(1):99-100.

PMID:
9778793
33.

Characterization of bovine adenovirus type 3 early region 2B.

Baxi MK, Reddy PS, Zakhartchouk AN, Idamakanti N, Pyne C, Babiuk LA, Tikoo SK.

Virus Genes. 1998;16(3):313-6.

PMID:
9654686
34.

Nucleotide sequence, genome organization, and transcription map of bovine adenovirus type 3.

Reddy PS, Idamakanti N, Zakhartchouk AN, Baxi MK, Lee JB, Pyne C, Babiuk LA, Tikoo SK.

J Virol. 1998 Feb;72(2):1394-402.

35.
36.

Characterization of the early region 4 of porcine adenovirus type 3.

Reddy PS, Idamakanti N, Derbyshire JB, Nagy E.

Virus Genes. 1997;15(1):87-90.

PMID:
9354276
37.

Porcine adenoviruses types 1, 2 and 3 have short and simple early E-3 regions.

Reddy PS, Idamakanti N, Derbyshire JB, Nagy E.

Virus Res. 1996 Aug;43(2):99-109.

PMID:
8864200

Supplemental Content

Loading ...
Support Center